{"date":"2026-01-22","count":20,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2026-01-22-2301-1x3ky28","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"23:01:43","subject":"代子公司英屬開曼群島商霖揚藥業股份有限公司公告更換董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-22 23:01，「代子公司英屬開曼群島商霖揚藥業股份有限公司公告更換董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-01-22-2301-zxtyeb","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"23:01:02","subject":"代重要子公司霖揚生技製藥股份有限公司公告更換董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-22 23:01，「代重要子公司霖揚生技製藥股份有限公司公告更換董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-01-22-1816-hnlzq3","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-22","time":"18:16:16","subject":"更正本公司114年12月份為他人背書保證申報資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-01-22 18:16，「更正本公司114年12月份為他人背書保證申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-01-22-1734-1fzpk3t","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"17:34:03","subject":"公告本公司114年度現金增資認股基準日暨相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-01-22 17:34，「公告本公司114年度現金增資認股基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-01-22-1707-1x3ouqx","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"17:07:46","subject":"公告本公司資安長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-22 17:07，「公告本公司資安長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-01-22-1706-l7qirp","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"17:06:51","subject":"公告本公司會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-01-22 17:06，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-01-22-1649-1tfv51g","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-01-22","time":"16:49:02","subject":"本公司受邀參加J.P. Morgan舉辦之Healthcare Conference Taipei 2026法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-01-22 16:49，「本公司受邀參加J.P. Morgan舉辦之Healthcare Conference Taipei 2026法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-01-22-1617-1oqwc49","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"16:17:38","subject":"公告本公司取得不動產相關事宜","clause":"第17款","fact_date":"2026-01-22","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-01-22 16:17，「公告本公司取得不動產相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-01-22-1600-6rqyk5","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"16:00:51","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-01-22","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-01-22 16:00，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-01-22-1537-jeskrg","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"15:37:49","subject":"公告本公司114年現金增資發行新股委託代收股款及存儲專戶行庫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-01-22 15:37，「公告本公司114年現金增資發行新股委託代收股款及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-01-22-1535-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"15:35:02","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-01-22 15:35，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-01-22-1519-122zq44","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"15:19:51","subject":"公告本公司114年第四季財務報告董事會預計召開日期為115年01月30日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-01-22 15:19，「公告本公司114年第四季財務報告董事會預計召開日期為115年01月30日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-01-22-1511-6r1evi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"15:11:10","subject":"公告本公司董事會決議限制型員工權利新股收回減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-01-22 15:11，「公告本公司董事會決議限制型員工權利新股收回減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-01-22-1510-5rax5d","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"15:10:00","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-01-22 15:10，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-01-22-1508-qh0ukk","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"15:08:46","subject":"代公告改派子公司朗齊株式會社總經理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-01-22 15:08，「代公告改派子公司朗齊株式會社總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-01-22-1448-1eymzho","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-01-22","time":"14:48:31","subject":"公告本公司自行撤回現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-01-22 14:48，「公告本公司自行撤回現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2026-01-22-1340-1237cgc","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"13:40:58","subject":"本公司配合會計師建議更正本公司原114年12月營收公告數","clause":"第51款","fact_date":"2026-01-22","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2026-01-22 13:40，「本公司配合會計師建議更正本公司原114年12月營收公告數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-01-22-1327-fh8jr9","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"13:27:19","subject":"本公司取得衛福部食品藥物管理署核發藥證","clause":"第10款","fact_date":"2026-01-22","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-01-22 13:27，「本公司取得衛福部食品藥物管理署核發藥證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-01-22-1057-441vkr","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-01-22","time":"10:57:34","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-01-22 10:57，「公告本公司股票初次上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-01-22-0958-1fqkmsr","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-22","time":"09:58:05","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-01-22 09:58，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}